Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bluemtec CoXKRX:439580 +1.01%47 Market Cap is ₩67,558 Mil as of Sep. 04, 2026. GuruFocus rates XKRX:439580 with a GF Score™ of 47/100 and a GF Value™ of ₩6,818.30 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 690 Healthcare Providers & Services companies, Bluemtec Co ranks worse than 62.17% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bluemtec Co's share price for the quarter that ended in Jun. 2026 was ₩1907. Bluemtec Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 34 Mil. Therefore, Bluemtec Co's market cap for the quarter that ended in Jun. 2026 was ₩64,546 Mil.
Bluemtec Co's quarterly market cap
declined
from Dec. 2025 (₩149,604 Mil) to Mar. 2026 (₩112,541 Mil) and
declined
from Mar. 2026 (₩112,541 Mil) to Jun. 2026 (₩64,546 Mil).
Bluemtec Co's annual market cap
declined
from Dec. 2023 (₩289,157 Mil) to Dec. 2024 (₩132,257 Mil) but then
increased
from Dec. 2024 (₩132,257 Mil) to Dec. 2025 (₩149,604 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bluemtec Co's Enterprise Value for Today is ₩96,894 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bluemtec Co Market Cap Related Terms
Bluemtec Co Market Cap Historical Data
* Premium members only.
The historical data trend for Bluemtec Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Bluemtec Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bluemtec Co Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bluemtec Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Bluemtec Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bluemtec Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bluemtec Co (XKRX:439580) has a Market Cap of ₩67,558 Mil as of Sep. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bluemtec Co and its competitors. According to the industry distribution chart, Bluemtec Co ranks #429 out of 690 companies in the Healthcare Providers & Services industry, placing it in the top 62.2%.
Is Bluemtec Co's Market Cap too high?
Bluemtec Co's current Market Cap is ₩67,558 Mil. Based on the distribution chart, Bluemtec Co ranks #429 out of 690 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Bluemtec Co has a GF Score™ of 47/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bluemtec Co's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Bluemtec Co ranks #429 out of 690 companies for Market Cap. This places Bluemtec Co in the lower half of its industry. The industry median Market Cap is 109.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 109.36, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bluemtec Co and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 109.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bluemtec Co's current Market Cap is ₩67,558 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bluemtec Co stock overvalued right now?
Based on GuruFocus' analysis, Bluemtec Co (XKRX:439580) is currently considered Significantly Undervalued. The stock's GF Value™ is ₩6,818.30, compared to a current price of ₩1,996.00 — trading 70.7% below its estimated fair value. The current Market Cap is ₩67,558 Mil. Bluemtec Co's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bluemtec Co (XKRX:439580), the current Market Cap is ₩67,558 Mil as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bluemtec Co (XKRX:439580) Overvalued in 2026?
Based on GuruFocus' analysis, Bluemtec Co stock appears to be undervalued.
The current stock price of ₩1,996.00 is trading 70.7% below its estimated GF Value™ of ₩6,818.30.
GuruFocus considers Bluemtec Co to be Significantly Undervalued.
Key valuation signals for XKRX:439580:
Market Cap: ₩67,558 Mil
GF Value™: ₩6,818.30 vs. price of ₩1,996.00 (70.7% below fair value)
No single metric tells the full story. See the XKRX:439580 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, it is operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.
47GF Score
Get the complete analysis for XKRX:439580
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:439580 has been successfully added to your 
